Citation

Kang SG, Park YM, Lee HJ, Yoon B. Psychiatry Investig. 2011; 8(3): 269-271.

Copyright

(Copyright © 2011, Korean Neuropsychiatric Association)

DOI

10.4306/pi.2011.8.3.269

PMID

unavailable

Abstract

Duloxetine is a balanced serotonin-norepinephrine reuptake inhibitor. Duloxetine-induced liver injury in patients with preexisting liver disease or chronic alcohol use is known. However, we have found that duloxetine can also induce liver injury in cases without those risk factors. We recommend that clinicians should monitor liver function carefully following duloxetine treatment. © 2011 Korean Neuropsychiatric Association.

Language: en

Keywords

adult; human; female; male; aged; case report; Major depressive disorder; suicide attempt; major depression; treatment outcome; fatigue; article; mirtazapine; venlafaxine; quetiapine; albumin; drug withdrawal; side effect; duloxetine; escitalopram; alanine aminotransferase; aspartate aminotransferase; Duloxetine; laboratory test; protein; treatment response; amylase; toxic hepatitis; drug dose increase; bilirubin; drug substitution; liver function test; Liver injury